nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—UGT1A9—Metabolism—SLC16A8—age related macular degeneration	0.00191	0.00191	CbGpPWpGaD
Haloperidol—DRD1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00191	0.00191	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—RHO—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—CD36—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Haloperidol—DRD3—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—RHO—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00187	0.00187	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00187	0.00187	CbGpPWpGaD
Haloperidol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Haloperidol—DRD2—G alpha (i) signalling events—C3—age related macular degeneration	0.00182	0.00182	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—ABCA4—age related macular degeneration	0.00181	0.00181	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—ABCA4—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—RHO—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—ABCA4—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Haloperidol—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00173	0.00173	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—RHO—age related macular degeneration	0.00172	0.00172	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—RHO—age related macular degeneration	0.00171	0.00171	CbGpPWpGaD
Haloperidol—EBP—Metabolism—APOE—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Haloperidol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RDH8—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Haloperidol—HTR1D—GPCR ligand binding—C3—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—APOE—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—ABCA4—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Haloperidol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Haloperidol—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RDH8—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RDH8—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Haloperidol—HTR1B—GPCR ligand binding—C3—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Haloperidol—DRD4—GPCR ligand binding—C3—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—SLC16A8—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Haloperidol—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—RHO—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—ABCA4—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Haloperidol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—NMNAT1—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—ABCA4—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Haloperidol—HTR2B—GPCR ligand binding—C3—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—RHO—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—RHO—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Haloperidol—GRIN2B—Axon guidance—VEGFA—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Haloperidol—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Haloperidol—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RPE65—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Haloperidol—DRD1—GPCR ligand binding—C3—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—RHO—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RPE65—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Haloperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RPE65—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Haloperidol—DRD3—GPCR ligand binding—C3—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Haloperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Haloperidol—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RHO—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ELOVL4—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Haloperidol—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RHO—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Haloperidol—HTR1D—GPCR ligand binding—CCL2—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Haloperidol—HTR1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Haloperidol—DRD4—GPCR ligand binding—CCL2—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Haloperidol—HTR2A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Haloperidol—HTR2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ABCA4—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Haloperidol—DRD1—GPCR ligand binding—CCL2—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Haloperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Haloperidol—DRD3—GPCR ligand binding—CCL2—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Haloperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Haloperidol—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—SLC16A8—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—C3—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—C3—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—VEGFA—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RHO—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RHO—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000997	0.000997	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000994	0.000994	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—LIPC—age related macular degeneration	0.000979	0.000979	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—C3—age related macular degeneration	0.000949	0.000949	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CETP—age related macular degeneration	0.000944	0.000944	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000942	0.000942	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—C3—age related macular degeneration	0.000929	0.000929	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000925	0.000925	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—C3—age related macular degeneration	0.000914	0.000914	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000909	0.000909	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.000899	0.000899	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.000884	0.000884	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000877	0.000877	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—C3—age related macular degeneration	0.000873	0.000873	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000869	0.000869	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000865	0.000865	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—C3—age related macular degeneration	0.000862	0.000862	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.00086	0.00086	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TGFBR1—age related macular degeneration	0.000851	0.000851	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000847	0.000847	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—CCL2—age related macular degeneration	0.000845	0.000845	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—C3—age related macular degeneration	0.000844	0.000844	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—C3—age related macular degeneration	0.00083	0.00083	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000827	0.000827	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—LIPC—age related macular degeneration	0.000823	0.000823	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—C3—age related macular degeneration	0.000823	0.000823	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.00082	0.00082	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000813	0.000813	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—C3—age related macular degeneration	0.000812	0.000812	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000805	0.000805	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000801	0.000801	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CETP—age related macular degeneration	0.000794	0.000794	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—C3—age related macular degeneration	0.000792	0.000792	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000784	0.000784	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000777	0.000777	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SQSTM1—age related macular degeneration	0.000772	0.000772	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000767	0.000767	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000766	0.000766	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000756	0.000756	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—C3—age related macular degeneration	0.000747	0.000747	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—C3—age related macular degeneration	0.000737	0.000737	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000737	0.000737	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000732	0.000732	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.0007	0.0007	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000695	0.000695	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000686	0.000686	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000674	0.000674	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000671	0.000671	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000667	0.000667	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—CCL2—age related macular degeneration	0.00066	0.00066	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—CCL2—age related macular degeneration	0.00065	0.00065	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000646	0.000646	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000621	0.000621	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—CCL2—age related macular degeneration	0.00062	0.00062	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000611	0.000611	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—C3—age related macular degeneration	0.00061	0.00061	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000599	0.000599	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000595	0.000595	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—CCL2—age related macular degeneration	0.000585	0.000585	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000579	0.000579	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—CCL2—age related macular degeneration	0.000577	0.000577	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CETP—age related macular degeneration	0.000574	0.000574	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000569	0.000569	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000568	0.000568	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CD36—age related macular degeneration	0.000568	0.000568	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000564	0.000564	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—LIPC—age related macular degeneration	0.000562	0.000562	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000555	0.000555	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—C3—age related macular degeneration	0.000554	0.000554	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000546	0.000546	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CETP—age related macular degeneration	0.000542	0.000542	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.00054	0.00054	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000528	0.000528	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000525	0.000525	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000516	0.000516	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000515	0.000515	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—C3—age related macular degeneration	0.000509	0.000509	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—APOE—age related macular degeneration	0.000501	0.000501	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—C3—age related macular degeneration	0.000498	0.000498	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—C3—age related macular degeneration	0.00049	0.00049	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000482	0.000482	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CD36—age related macular degeneration	0.000477	0.000477	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—APOE—age related macular degeneration	0.000474	0.000474	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—C3—age related macular degeneration	0.000468	0.000468	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000467	0.000467	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—KDR—age related macular degeneration	0.000464	0.000464	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—APOE—age related macular degeneration	0.000464	0.000464	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.00046	0.00046	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—APOE—age related macular degeneration	0.000457	0.000457	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—KDR—age related macular degeneration	0.000455	0.000455	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000449	0.000449	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—KDR—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000444	0.000444	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000442	0.000442	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—C3—age related macular degeneration	0.000441	0.000441	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—APOE—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—C3—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000434	0.000434	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CCL2—age related macular degeneration	0.000433	0.000433	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CETP—age related macular degeneration	0.000433	0.000433	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—KDR—age related macular degeneration	0.000427	0.000427	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000423	0.000423	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—APOE—age related macular degeneration	0.000421	0.000421	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.00042	0.00042	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000412	0.000412	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—APOE—age related macular degeneration	0.000411	0.000411	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000408	0.000408	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—APOE—age related macular degeneration	0.000406	0.000406	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000405	0.000405	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—KDR—age related macular degeneration	0.000403	0.000403	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CCL2—age related macular degeneration	0.000398	0.000398	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—KDR—age related macular degeneration	0.000397	0.000397	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CCL2—age related macular degeneration	0.00039	0.00039	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CCL2—age related macular degeneration	0.000384	0.000384	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CCL2—age related macular degeneration	0.000366	0.000366	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000358	0.000358	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000346	0.000346	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCL2—age related macular degeneration	0.000345	0.000345	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CD36—age related macular degeneration	0.000345	0.000345	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCL2—age related macular degeneration	0.000341	0.000341	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000333	0.000333	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000328	0.000328	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—C3—age related macular degeneration	0.000327	0.000327	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CD36—age related macular degeneration	0.000326	0.000326	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.00031	0.00031	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000305	0.000305	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—APOE—age related macular degeneration	0.000305	0.000305	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—APOE—age related macular degeneration	0.000304	0.000304	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000304	0.000304	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000299	0.000299	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KDR—age related macular degeneration	0.000298	0.000298	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—APOE—age related macular degeneration	0.000288	0.000288	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000277	0.000277	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000267	0.000267	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000267	0.000267	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000261	0.000261	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CD36—age related macular degeneration	0.00026	0.00026	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000257	0.000257	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCL2—age related macular degeneration	0.000256	0.000256	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000256	0.000256	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—age related macular degeneration	0.00025	0.00025	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—age related macular degeneration	0.000246	0.000246	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000245	0.000245	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000243	0.000243	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOE—age related macular degeneration	0.000235	0.000235	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000235	0.000235	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOE—age related macular degeneration	0.00023	0.00023	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—age related macular degeneration	0.000222	0.000222	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—age related macular degeneration	0.000219	0.000219	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000216	0.000216	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000215	0.000215	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000208	0.000208	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000183	0.000183	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.000167	0.000167	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000165	0.000165	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—age related macular degeneration	0.000164	0.000164	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CD36—age related macular degeneration	0.00016	0.00016	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000142	0.000142	CbGpPWpGaD
